Can Fite (Israel) Odds of Future Stock Price Finishing Over 245.37
CANF Stock | 2.60 0.10 3.70% |
Can |
Can Fite Target Price Odds to finish over 245.37
The tendency of Can Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current Price | Horizon | Target Price | Odds to move over 245.37 or more in 90 days |
2.60 | 90 days | 245.37 | close to zero percent |
Based on a normal probability distribution, the odds of Can Fite to move over 245.37 or more in 90 days from now is close to zero percent (This Can Fite Biopharma probability density function shows the probability of Can Stock to fall within a particular range of prices over 90 days) . Probability of Can Fite Biopharma price to stay between its current price of 2.60 and 245.37 at the end of the 90-day period is about 75.88 .
Assuming the 90 days trading horizon Can Fite Biopharma has a beta of -0.44 suggesting as returns on the benchmark increase, returns on holding Can Fite are expected to decrease at a much lower rate. During a bear market, however, Can Fite Biopharma is likely to outperform the market. Additionally Can Fite Biopharma has an alpha of 0.0531, implying that it can generate a 0.0531 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta). Can Fite Price Density |
Price |
Predictive Modules for Can Fite
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Can Fite Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Can Fite's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Can Fite Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Can Fite is not an exception. The market had few large corrections towards the Can Fite's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Can Fite Biopharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Can Fite within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | 0.05 | |
β | Beta against NYSE Composite | -0.44 | |
σ | Overall volatility | 0.10 | |
Ir | Information ratio | -0.01 |
Can Fite Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Can Fite for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Can Fite Biopharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.Can Fite Biopharma has high likelihood to experience some financial distress in the next 2 years | |
The company reported the revenue of 853 K. Net Loss for the year was (12.62 M) with profit before overhead, payroll, taxes, and interest of 853 K. | |
Can Fite Biopharma has accumulated about 3.21 M in cash with (9.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.07. |
Can Fite Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Can Stock often depends not only on the future outlook of the current and potential Can Fite's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Can Fite's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 815.7 M |
Can Fite Technical Analysis
Can Fite's future price can be derived by breaking down and analyzing its technical indicators over time. Can Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Can Fite Biopharma. In general, you should focus on analyzing Can Stock price patterns and their correlations with different microeconomic environments and drivers.
Can Fite Predictive Forecast Models
Can Fite's time-series forecasting models is one of many Can Fite's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Can Fite's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Can Fite Biopharma
Checking the ongoing alerts about Can Fite for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Can Fite Biopharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Can Fite Biopharma has high likelihood to experience some financial distress in the next 2 years | |
The company reported the revenue of 853 K. Net Loss for the year was (12.62 M) with profit before overhead, payroll, taxes, and interest of 853 K. | |
Can Fite Biopharma has accumulated about 3.21 M in cash with (9.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.07. |
Check out Can Fite Backtesting, Can Fite Valuation, Can Fite Correlation, Can Fite Hype Analysis, Can Fite Volatility, Can Fite History as well as Can Fite Performance. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Can Stock analysis
When running Can Fite's price analysis, check to measure Can Fite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Can Fite is operating at the current time. Most of Can Fite's value examination focuses on studying past and present price action to predict the probability of Can Fite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Can Fite's price. Additionally, you may evaluate how the addition of Can Fite to your portfolios can decrease your overall portfolio volatility.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |